Stocks · Korea 049180 KOSDAQ

Cellumed

1,009원 +0.00% Market cap 840억 2026-10-07 close
Data as of 2026-10-07 · Linked from 6 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER—
PBR6.59x
EPS0 KRW
BPS153 KRW
ROE-10.54%
DPS0 KRW

Returns and 52-week range

1W+0.00%
1M+0.00%
3M+0.00%
6M+0.00%
1Y+37.84%
YTD+24.88%
52W high2,975원
52W low—
From 52W high-66.08%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
20221,221억-27억-54억-2.2%
2023956억-105억-379억-10.9%
20241,291억-68억-318억-5.3%
20251,402억-51억-22억-3.7%
Quarterly
2024 4Q366억-34억-255억-9.4%
2025 1Q392억-16억-14억-4.1%
2025 2Q354억-43억-25억-12.2%
2025 3Q373억14억80억3.9%
2025 4Q283억-6억-63억-2.3%
2026 1Q234억-16억-17억-6.7%

Company

CEO유인수
Founded1985-04-30
Fiscal year end12
Address: 서울특별시 금천구 디지털로 130 402(가산동, 에이스테크노타워 9차)

Peers in the same sector

CompanyMarket capP/EP/B1M
테라젠이텍스842억7.650.60+8.96%
엔지켐생명과학838억—0.54+0.00%
대봉엘에스845억8.290.59-4.51%
CMG제약832억—0.41-9.79%
중앙백신853억14.040.81-0.86%
종근당바이오827억—0.65+10.81%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.